Myriad Genetics (MYGN) Stock: Buy, Sell, or Hold?
MYGN - Myriad Genetics Inc
$3.42
0.06 (1.79%)
▲
5d:
+5.88%
30d:
+5.88%
90d:
-26.13%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 02, 2026
Get Alerted When MYGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MYGN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MYGN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MYGN is currently trading at $3.42, which is considered extended relative to its 30-day fair value range of $3.07 to $3.28. From a valuation perspective, the stock is trading at a discount (Forward PE: -6.0) compared to its historical average (50.8). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MYGN is in a downtrend. The price is approaching resistance at $3.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MYGN scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MYGN is in a downtrend. The price is approaching resistance at $3.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MYGN scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.07 -
$3.28
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
28.6%
Protect Your Profits
Holding MYGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($3.37)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.07 -
$3.28
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.92
Resistance Level
$3.43
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.97
Wall Street Target
$3.37
(-1.6%)
Revenue Growth (YoY)
-20.8%
Profit Margin
-41.3%
PE vs Historical
-6.0 vs 50.8
CHEAP
Share & Embed Analysis
Last updated: September 13, 2026 10:42 AM ET
Data refreshes hourly during market hours. Next update: 11:42 AM
Data refreshes hourly during market hours. Next update: 11:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MYGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$645 | 51 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$229 | 49 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 49 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$344 | 47 HOLD |
Advanced MYGN Option Strategies
Professional options setups generated by AI based on today's MYGN price and gamma walls.
